Effects of nebulized inhalation in the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease
Bai Jin-chuan
Abstract
Bai Jin-chuan
Abstract
Objective To investigate the efficacy of nebulized inhalation of ambroxol combined with budesonide,ipratropium bromide and salbutamol in the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease(AECOPD).Methods 212 patients with AECOPD were randomly into group A(n=106) and group B(n=106).The basic treatments for two groups included intravenous antibiotics,antiasthmantics and apophlegmatisant.The group A was given inhalation of ambroxol combined budesonide,ipratropium bromide and salbutamol.The group B was given budesonide,ipratropium bromide and salbutamol.The pulmonary function and changes in dyspnea grade were compared between both groups before and after treatment.Results Patients in the group A were significantly improved than those in group B on pulmonary function(FEV1,FEV1/FVC,FEV1% Pred) and changes in dyspnea grade after the therapy(P0.01).Conclusion The therapy of inhalation ambroxol combined with budesonide,ipratropium bromide and salbutamol may effectively relieve the symptoms of AECOPD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the efficacy of nebulized inhalation of ambroxol combined with budesonide,ipratropium bromide and salbutamol in the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease(AECOPD).Methods 212 patients with AECOPD were randomly into group A(n=106) and group B(n=106).The basic treatments for two groups included intravenous antibiotics,antiasthmantics and apophlegmatisant.The group A was given inhalation of ambroxol combined budesonide,ipratropium bromide and salbutamol.The group B was given budesonide,ipratropium bromide and salbutamol.The pulmonary function and changes in dyspnea grade were compared between both groups before and after treatment.Results Patients in the group A were significantly improved than those in group B on pulmonary function(FEV1,FEV1/FVC,FEV1% Pred) and changes in dyspnea grade after the therapy(P0.01).Conclusion The therapy of inhalation ambroxol combined with budesonide,ipratropium bromide and salbutamol may effectively relieve the symptoms of AECOPD.
Key concepts: Ipratropium bromide, Medicine, Salbutamol, Budesonide, Ambroxol, Inhalation, Anesthesia, Pulmonary function testing